1. null
    Günter Köhler et al, 2018 CrossRef
  2. null
    Andrea Tinelli et al, 2018 CrossRef
  3. Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report
    Mary M. Mullen et al, 2017, Gynecologic Oncology Reports CrossRef
  4. Leiomyosarcoma: A rare soft tissue cancer arising from multiple organs
    Zorawar Singh, 2017, Journal of Cancer Research and Practice CrossRef
  5. The Regulatory Function of miR-200c on Inflammatory and Cell-Cycle Associated Genes in SK-LMS-1, A Leiomyosarcoma Cell Line
    Tsai-Der Chuang et al, 2015, Reprod Sci CrossRef
  6. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
    Qing Zhang et al, 2018, Hum Pathol CrossRef
  7. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells
    Bruna de Almeida et al, 2017, IJMS CrossRef
  8. Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition
    Carla B. Ripamonti et al, 2017, Cancer Genetics CrossRef
  9. Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes
    Julia Manzerova et al, 2016, Gynecologic Oncology CrossRef
  10. null
    Roberta Zappacosta et al, 2018 CrossRef
  11. INTERRELATION OF STEROID RECEPTOR GENE EXPRESSION IN UTERINE TISSUES AND SERUM CONCENTRATIONS OF IMMUNOREGULATORY PROTEINS, CYTOKINES, SEX STEROIDS IN PROLIFERATIVE DISEASES
    S. V. Shramko et al, 2018, Med. immunol. CrossRef
  12. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas
    Terhi V. Ahvenainen et al, 2018, Cancer CrossRef
  13. Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas†
    Aymara Mas et al, 2018 CrossRef
  14. Different methylation levels in the KLF4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM
    Dušan Braný, 2019, Pathology - Research and Practice CrossRef
  15. null
    Leonardo Resta, 2015 CrossRef
  16. null
    Anupama Rajanbabu, 2015 CrossRef
  17. null
    Monisha Gupta et al, 2015 CrossRef
  18. null
    Gauravi Mishra et al, 2015 CrossRef
  19. null
    Qing Zhang et al, 2016 CrossRef
  20. Therapeutic Implication of Genomic Landscape of Adult Metastatic Sarcoma
    Xiaolan Feng et al, 2019, JCO Precision Oncology CrossRef
  21. Adjuvant management of operated uterine sarcomas: A single institution experience
    A. Cordoba et al, 2019, Cancer/Radiothérapie CrossRef
  22. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing
    Aymara Mas et al, 2019, American Journal of Obstetrics and Gynecology CrossRef
  23. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri
    Dana Dvorská et al, 2019, IJMS CrossRef
  24. Next-generation Sequencing of an Ovarian Spindle Cell Tumor Identified an Ovarian Low-grade Endometrial Stromal Sarcoma
    Youn Jin Choi et al, 2019, International Journal of Gynecological Pathology CrossRef
  25. Targeted genomic analysis of Müllerian adenosarcoma
    Brooke E Howitt et al, 2015, J. Pathol. CrossRef
  26. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?
    Natalia Garcia et al, 2016, Human Pathology CrossRef
  27. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers
    Lorna Rodriguez-Rodriguez et al, 2016, Gynecologic Oncology CrossRef
  28. Survivin and gynaecological tumours
    Dušan Braný et al, 2017, Pathology - Research and Practice CrossRef
  29. Vaginal metastasis as the initial presentation of leiomyosarcoma: a case report
    Cecilia Villalaín-González et al, 2017, BMC Cancer CrossRef
  30. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma
    M. Ludovisi et al, 2019, Ultrasound Obstet Gynecol CrossRef
  31. Advanced uterine adenosarcoma with sarcomatous overgrowth in a young woman
    Bin Wang et al, 2019, Medicine CrossRef
  32. Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-p53 Combined with Chemotherapy Treatment
    Yu Xia et al, 2020, Human Gene Therapy CrossRef
  33. The Role of Eicosanoids in Gynecological Malignancies
    Paige G. Smith et al, 2020, Front. Pharmacol. CrossRef
  34. S2k-Leitlinie Diagnostik und Therapie uteriner Sarkome – Anforderungen an die Pathologie
    Lars-Christian Horn et al, 2020, Pathologe CrossRef
  35. Biomaterial strategies to replicate gynecological tissue
    Ines Cadena et al, 2020, Biomater. Sci. CrossRef
  36. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study
    Leonardo Tomiatti da Costa et al, 2021 CrossRef
  37. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
    Maja Sabol, 0 CrossRef
  38. Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm
    Xiaoqing Shen et al, 2021, World J Surg Onc CrossRef
  39. Leiomyosarcoma of the Uterus: A Rare Diagnosis
    Palak Paudel et al, 2021 CrossRef
  40. Uterine carcinosarcoma with extensive extrauterine component
    Pedro Carvalho Almeida et al, 2021, BMJ Case Rep CrossRef
  41. Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies
    Rajeev K. Singla et al, 2022, Front. Pharmacol. CrossRef
  42. null
    Mohamed Otify et al, 2020 CrossRef
  43. Comparative whole transcriptome analysis of gene expression in three canine soft tissue sarcoma types
    Lydia Lam et al, 2022, PLoS ONE CrossRef
  44. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature
    Bruna Cristine de Almeida et al, 2022, Biomedicines CrossRef
  45. DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma
    Yumin Ke et al, 2022, Front. Oncol. CrossRef
  46. Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Comprehensive Multidisciplinary Update
    Andrea Tinelli et al, 2023, Medicina CrossRef
  47. Current Treatment Options: Uterine Sarcoma
    Dana Lewis et al, 2024, Curr. Treat. Options in Oncol. CrossRef
  48. Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Case Report and Literature Review
    文迪 赵, 2024, ACM CrossRef
  49. Exploring the Clinicopathological Diversity in Sarcomatous Transformations in the Uterus
    Neelayadakshi B et al, 2024 CrossRef
  50. The role of extracellular vesicles in the pathogenesis of gynecological cancer
    Madhura Chatterjee et al, 2024, Front. Oncol. CrossRef
  51. Preoperative identification from occult leiomyosarcomas in laparoscopic hysterectomy and laparoscopic myomectomy: accuracy of the ultrasound scoring system (PRESS-US)
    Zhuolin Jiang et al, 2024, Radiol med CrossRef
  52. Leiomiossarcoma de Vagina em Paciente Gestante: Relato de Caso
    Amanda de Queiroz Piffer et al, 2025, Rev. Bras. Cancerol. CrossRef